Li Yishan (CIK 1772233) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy BLSM (1.6M shares), Buy BLSM (113,435 shares), Buy BLSM (124,779 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | BlossomHill Therapeutics, Inc. (BLSM) | Executive Chairman | Buy | 1.6M | $0 |
| 2026-08-10 | BlossomHill Therapeutics, Inc. (BLSM) | Executive Chairman | Buy | 113,435 | $0 |
| 2026-08-10 | BlossomHill Therapeutics, Inc. (BLSM) | Executive Chairman | Buy | 124,779 | $0 |
Source: SEC Form 4 filings · as of 2026-08-10